2-Phenylquinoline

2-Phenylquinoline

SCHEMBL346742

[In].c1ccc(-c2ccc3ccccc3n2)cc1.c1ccc(-c2ccc3ccccc3n2)cc1.c1ccc(-c2ccc3ccccc3n2)cc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 14/20 0.70
NPC1 O15118 12/20 0.70
AR P10275 2/20 0.70
CYP3A4 P08684 2/20 0.70
CYP1A2 P05177 1/20 0.70
CYP2D6 P10635 1/20 0.70
CYP2C9 P11712 1/20 0.70
CYP2C19 P33261 1/20 0.70
MEN1 O00255 4/20 0.68
KMT2A Q03164 4/20 0.68
KDM4E B2RXH2 8/20 0.66
SMN1; SMN2 Q16637 7/20 0.66
ALDH1A1 P00352 7/20 0.66
MAPT P10636 5/20 0.66
HSD17B10 Q99714 4/20 0.66
TP53 P04637 3/20 0.66
PKM P14618 3/20 0.66
HPGD P15428 3/20 0.66
GMNN O75496 1/20 0.66
THPO P40225 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Phenylquinoline SCHEMBL29399739 0.98 RAB9A (0.73) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL44999 0.98 RAB9A (0.73) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL29498037 0.95 RAB9A (0.70) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL29986142 0.95 RAB9A (0.70) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL668531 0.95 RAB9A (0.70) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL1815021 0.95 RAB9A (0.70) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL5733254 0.95 RAB9A (0.70) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL6858671 0.95 RAB9A (0.70) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL28871326 0.95 RAB9A (0.70) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL28983 0.95 RAB9A (0.70) RAB9ANPC1ARCYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968229-B2 Seven-membered ring compounds IDEMITSU KOSAN CO., LTD. (JP) 2021-04-06 US disclosed
US-10584126-B2 1-functionalized dibenzofurans and dibenzothiophenes for organic light emitting diodes (OLEDs) IDEMITSU KOSAN CO., LTD. (JP) 2020-03-10 US disclosed
US-20190119291-A1 SEVEN-MEMBERED RING COMPOUNDS IDEMITSU KOSAN CO., LTD. (JP) 2019-04-25 US disclosed
US-20170362241-A1 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) IDEMITSU KOSAN CO., LTD. (JP) 2017-12-21 US disclosed
US-9458182-B2 Silyl- and heteroatom-substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and dibenzophospholes, and use thereof in organic electronics BASF SE (DE) 2016-10-04 US disclosed
US-20120012821-A1 SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119291-A1 SEVEN-MEMBERED RING COMPOUNDS MCM7, XPO7, LUC7L2 RAB9A 100/4885NPC1 923/4885AR 3285/4885
US-10584126-B2 1-functionalized dibenzofurans and dibenzothiophenes for organic light emitting diodes (OLEDs) OCIAD1, OCIAD2, DDT RAB9A 2312/4885NPC1 817/4885AR 4486/4885
US-10968229-B2 Seven-membered ring compounds MCM7, XPO7, LUC7L2 RAB9A 100/4885NPC1 923/4885AR 3285/4885
US-20120012821-A1 SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS DDT, CDKL1, CDK2 RAB9A 3555/4885NPC1 4516/4885AR 4318/4885
US-20170362241-A1 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) OCIAD1, OCIAD2, DDT RAB9A 2312/4885NPC1 817/4885AR 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.